home All News open_in_new Full Article

Profound Medical Regains Exclusive Distribution Rights for TULSA

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that it has regained exclusive distribution rights for TULSA-PRO® in Canada from Knight Therapeutics […]


today 7 d. ago attach_file Other

attach_file Science
attach_file Society
attach_file Economics
attach_file Sport
attach_file Other
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Society
attach_file Culture
attach_file Events
attach_file Science
attach_file Other
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Other


ID: 1971773554
Add Watch Country

arrow_drop_down